Cardiol Therapeutics Inc. Class A Stock Forecast
Evaluation of Cardiol Therapeutics Inc. Class A stock downgraded after the last trading session.
(Updated on May 02, 2024)
The Cardiol Therapeutics Inc. Class A stock price fell by -3.52% on the last day (Thursday, 2nd May 2024) from $2.84 to $2.74. During the last trading day the stock fluctuated 8.27% from a day low at $2.66 to a day high of $2.88. The price has been going up and down for this period, and there has been a 17.09% gain for the last 2 weeks. Volume has increased on the last day by 4 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 131 thousand shares were bought and sold for approximately $357.62 thousand.
The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $2.86 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 49.99% during the next 3 months and, with a 90% probability hold a price between $3.33 and $4.28 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
CRDL.TO Signals & Forecast
There are mixed signals in the stock today. A sell signal was issued from a pivot top point on Wednesday, May 01, 2024, and so far it has fallen -3.52%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Cardiol Therapeutics Inc. Class A gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The Cardiol Therapeutics Inc. Class A stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $2.59 and $2.41. A breakdown below any of these levels will issue sell signals.
Support, Risk & Stop-loss for Cardiol Therapeutics Inc. Class A stock
On the downside, the stock finds support just below today's level from accumulated volume at $2.50 and $2.47. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Cardiol Therapeutics Inc. Class A finds support just below today's level at $2.50. If this is broken, then the next support from accumulated volume will be at $2.47 and $2.34.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.220 between high and low, or 8.27%. For the last week, the stock has had daily average volatility of 8.82%.
Our recommended stop-loss: $2.63 (-4.18%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 1 day ago.)
Trading Expectations (CRDL.TO) For The Upcoming Trading Day Of Friday 3rd
For the upcoming trading day on Friday, 3rd we expect Cardiol Therapeutics Inc. Class A to open at $2.76, and during the day (based on 14 day Average True Range), to move between $2.54 and $2.94, which gives a possible trading interval of +/-$0.198 (+/-7.22%) up or down from last closing price. If Cardiol Therapeutics Inc. Class A takes out the full calculated possible swing range there will be an estimated 14.43% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $2.78 (1.46%) than the support at $2.50 (8.76%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Cardiol Therapeutics Inc. Class A stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Cardiol Therapeutics Inc. Class A stock to perform well in the short-term. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Buy candidate.
Current score: 1.628 Buy Candidate Downgraded
Predicted Opening Price for Cardiol Therapeutics Inc. Class A of Friday, May 3, 2024
Fair opening price May 3, 2024 | Current price |
---|---|
$2.76 ( 0.730%) | $2.74 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for CRDL.TO
Fibonacci Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 2.98 | 8.76 % | |
R2 | 2.90 | 5.69 % | ||
R1 | 2.84 | 3.80 % | ||
Current price: | 2.74 | |||
Support | S1 | 2.68 | -2.34 % | |
S2 | 2.62 | -4.23 % | ||
S3 | 2.54 | -7.30 % |
Accumulated Volume Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 2.84 | 3.65 % | |
R2 | 2.83 | 3.28 % | ||
R1 | 2.78 | 1.46 % | ||
Current price | 2.74 | |||
Support | S1 | 2.50 | -8.76% | |
S2 | 2.47 | -9.85% | ||
S3 | 2.34 | -14.78% |
FAQ
Click here for our free guide on how to buy Cardiol Therapeutics Inc. Class A Stock.